How to reduce morbidity and mortality from chest infections in rheumatoid arthritis

17Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

Abstract

Morbidity and mortality from pneumonia is increased in patients with rheumatoid arthritis. Factors contributing to this have been recently identified and a number of recommendations have been implemented in an attempt to reverse this trend. The present paper shows that these measures have combined to produce a fourfold reduction in both admissions and case fatality rates. In the study population, immunisation rates against influenza and pneumococcus have improved to 86% and 65%, oral steroid consumption has halved and disease modifying drugs were usually appropriately suspended during acute infection. These measures may now merit more wide-spread adoption. © Royal College of Physicians, 2010. All rights reserved.

Cite

CITATION STYLE

APA

Housden, M. M., Bell, G., Heycock, C. R., Hamilton, J., Saravanan, V., & Kelly, C. A. (2010). How to reduce morbidity and mortality from chest infections in rheumatoid arthritis. Clinical Medicine, Journal of the Royal College of Physicians of London, 10(4), 326–329. https://doi.org/10.7861/clinmedicine.10-4-326

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free